Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Sep;9(5):235-40.
doi: 10.1097/01.nrl.0000087722.46430.c4.

Update on Alzheimer drugs (galantamine)

Murray A Raskind  1
Affiliations
Review

Update on Alzheimer drugs (galantamine)

Murray A Raskind. Neurologist. 2003 Sep.

Abstract

Background: Deficient cholinergic function contributes to the cognitive and behavioral signs and symptoms of Alzheimer disease (AD). A successful treatment approach in AD has been the enhancement of cholinergic function by cholinesterase inhibitors.

Review summary: Galantamine is a cholinesterase inhibitor and allosteric modulating ligand at nicotinic cholinergic receptors. Galantamine 24 mg/d has been demonstrated consistently effective compared with placebo for the cognitive, functional, and behavioral aspects of Alzheimer's disease in large multicenter trials. Cognition and function on average are preserved for 12 months in Alzheimer disease patients receiving galantamine. It is safe and very well tolerated when dosage is escalated gradually.

Conclusions: Galantamine is a valuable addition to agents available for the pharmacologic treatment of AD.

PubMed Disclaimer

MeSH terms